Last reviewed · How we verify
Subanesthetic dose of esketamine
Subanesthetic dose of esketamine is a Small molecule drug developed by bo xu. It is currently in Phase 1 development. Also known as: Esketamine hydrochloride injection.
At a glance
| Generic name | Subanesthetic dose of esketamine |
|---|---|
| Also known as | Esketamine hydrochloride injection |
| Sponsor | bo xu |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyperactive Delirium (PHASE4)
- Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study (EARLY_PHASE1)
- The Effects of Subanesthetic S-ketamine on Postoperative Delirium and Cognitive Function in the Elderly Undergoing Non-cardiac Thoracic Surgery (EARLY_PHASE1)
- Chart Review of Patients Undergoing Ketamine Treatments for Depression
- Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients (NA)
- Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery (NA)
- Efficacy of Esketamine Combined With Different General Anesthetics on Quality of Postoperative Recovery (NA)
- Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Subanesthetic dose of esketamine CI brief — competitive landscape report
- Subanesthetic dose of esketamine updates RSS · CI watch RSS
- bo xu portfolio CI
Frequently asked questions about Subanesthetic dose of esketamine
What is Subanesthetic dose of esketamine?
Subanesthetic dose of esketamine is a Small molecule drug developed by bo xu.
Who makes Subanesthetic dose of esketamine?
Subanesthetic dose of esketamine is developed by bo xu (see full bo xu pipeline at /company/bo-xu).
Is Subanesthetic dose of esketamine also known as anything else?
Subanesthetic dose of esketamine is also known as Esketamine hydrochloride injection.
What development phase is Subanesthetic dose of esketamine in?
Subanesthetic dose of esketamine is in Phase 1.
Related
- Manufacturer: bo xu — full pipeline
- Also known as: Esketamine hydrochloride injection
- Compare: Subanesthetic dose of esketamine vs similar drugs
- Pricing: Subanesthetic dose of esketamine cost, discount & access